As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab. After the approval by the Drug Controller General of India (DCGI), the cultivation process has begun.
from Zee News :India National https://ift.tt/3i1gPc4
Tuesday, July 13, 2021